- •Preface and Acknowledgments
- •Contents
- •Contributors
- •1: Embryology for Urologists
- •Introduction
- •Renal Development
- •Pronephros
- •Mesonephros
- •Metanephros
- •Development of the Collecting System
- •Critical Steps in Further Development
- •Anomalies of the Kidney
- •Renal Agenesis
- •Renal Aplasia
- •Renal Hypoplasia
- •Renal Ectopia
- •Renal Fusion
- •Ureteral Development
- •Anomalies of Origin
- •Anomalies of Number
- •Incomplete Ureteral Duplication
- •Complete Ureteral Duplication
- •Ureteral Ectopia
- •Embryology of Ectopia
- •Clinical Correlation
- •Location of Ectopic Ureteral Orifices – Male (in Descending Order According to Incidence)
- •Symptoms
- •Ureteroceles
- •Congenital Ureteral Obstruction
- •Pipestem Ureter
- •Megaureter-Megacystis Syndrome
- •Prune Belly Syndrome
- •Vascular Ureteral Obstructions
- •Division of the Urogenital Sinus
- •Bladder Development
- •Urachal Anomalies
- •Cloacal Duct Anomalies
- •Other Bladder Anomalies
- •Bladder Diverticula
- •Bladder Extrophy
- •Gonadal Development
- •Testicular Differentiation
- •Ovarian Differentiation
- •Gonadal Anomalies
- •Genital Duct System
- •Disorders of Testicular Function
- •Female Ductal Development
- •Prostatic Urethral Valves
- •Gonadal Duct Anomalies
- •External Genital Development
- •Male External Genital Development
- •Female External Genital Development
- •Anomalies of the External Genitalia
- •References
- •2: Gross and Laparoscopic Anatomy of the Upper Urinary Tract and Retroperitoneum
- •Overview
- •The Kidneys
- •The Renal Vasculature
- •The Renal Collecting System
- •The Ureters
- •Retroperitoneal Lymphatics
- •Retroperitoneal Nerves
- •The Adrenal Glands
- •References
- •3: Gross and Laparoscopic Anatomy of the Lower Urinary Tract and Pelvis
- •Introduction
- •Female Pelvis
- •Male Pelvis
- •Pelvic Floor
- •Urinary Bladder
- •Urethra
- •Male Urethra
- •Female Urethra
- •Sphincter Mechanisms
- •The Bladder Neck Component
- •The Urethral Wall Component
- •The External Urethral Sphincter
- •Summary
- •References
- •4: Anatomy of the Male Reproductive System
- •Testis and Scrotum
- •Spermatogenesis
- •Hormonal Regulation of Spermatogenesis
- •Genetic Regulation of Spermatogenesis
- •Epididymis and Ductus Deferens
- •Accessory Sex Glands
- •Prostate
- •Seminal Vesicles
- •Bulbourethral Glands
- •Penis
- •Erection and Ejaculation
- •References
- •5: Imaging of the Upper Tracts
- •Anatomy of the Upper Tracts and Introduction to Imaging Modalities
- •Introduction
- •Renal Upper Tract Basic Anatomy
- •Modalities Used for Imaging the Upper Tracts
- •Ultrasound
- •Radiation Issues
- •Contrast Issues
- •Renal and Upper Tract Tumors
- •Benign Renal Tumors
- •Transitional Cell Carcinoma
- •Renal Mass Biopsy
- •Renal Stone Disease
- •Ultrasound
- •Plain Radiographs and IVU
- •Renal Cystic Disease
- •Benign Renal Cysts
- •Hereditary Renal Cystic Disease
- •Complex Renal Cysts
- •Renal Trauma
- •References
- •Introduction
- •Pathophysiology
- •Susceptibility and Resistance
- •Epidemiological Breakpoints
- •Clinical Breakpoints
- •Pharmacodynamic Parameters
- •Pharmacokinetic Parameters
- •Fosfomycin
- •Nitrofurantoin
- •Pivmecillinam
- •b-Lactam-Antibiotics
- •Penicillins
- •Cephalosporins
- •Carbapenems
- •Aminoglycosides
- •Fluoroquinolones
- •Trimethoprim, Cotrimoxazole
- •Glycopeptides
- •Linezolid
- •Conclusion
- •References
- •7: An Overview of Renal Physiology
- •Introduction
- •Body Fluid Compartments
- •Regulation of Potassium Balance
- •Regulation of Acid–Base Balance
- •Diuretics
- •Suggested Reading
- •8: Ureteral Physiology and Pharmacology
- •Ureteral Anatomy
- •Modulation of Peristalsis
- •Ureteral Pharmacology
- •Conclusion
- •References
- •Introduction
- •Afferent Signaling Pathways
- •Efferent Signaling
- •Parasympathetic Nerves
- •Sympathetic Nerves
- •Vesico-Spinal-Vesical Micturition Reflex
- •Peripheral Targets
- •Afferent Signaling Mechanisms
- •Urothelium
- •Myocytes
- •Cholinergic Receptors
- •Muscarinic Receptors
- •Nicotinic Receptors
- •Adrenergic Receptors (ARs)
- •a-Adrenoceptors
- •b-Adrenoceptors
- •Transient Receptor Potential (TRP) Receptors
- •Phosphodiesterases (PDEs)
- •CNS Targets
- •Opioid Receptors
- •Serotonin (5-HT) Mechanisms
- •g-Amino Butyric Acid (GABA) Mechanisms
- •Gabapentin
- •Neurokinin and Neurokinin Receptors
- •Summary
- •References
- •10: Pharmacology of Sexual Function
- •Introduction
- •Sexual Desire/Arousal
- •Endocrinology
- •Steroids in the Male
- •Steroids in the Female
- •Neurohormones
- •Neurotransmitters
- •Dopamine
- •Serotonin
- •Pharmacological Strategies
- •CNS Drugs
- •Enzyme-inducing Antiepileptic Drugs
- •Erectile Function
- •Ejaculatory Function
- •Premature Ejaculation
- •Abnormal Ejaculation
- •Conclusions
- •References
- •Epidemiology
- •Calcium-Based Urolithiasis
- •Uric Acid Urolithiasis
- •Infectious Urolithiasis
- •Cystine-Based Urolithiasis
- •Aims
- •Who Deserves Metabolic Evaluation?
- •Metabolic Workup for Stone Producers
- •Medical History and Physical Examination
- •Stone Analysis
- •Serum Chemistry
- •Urine Evaluation
- •Urine Cultures
- •Urinalysis
- •Twenty-Four Hour Urine Collections
- •Radiologic Imaging
- •Medical Management
- •Conservative Management
- •Increased Fluid Intake
- •Citrus Juices
- •Dietary Restrictions
- •Restricted Oxalate Diet
- •Conservative Measures
- •Selective Medical Therapy
- •Absorptive Hypercalciuria
- •Thiazide
- •Orthophosphate
- •Renal Hypercalciuria
- •Primary Hyperparathyroidism
- •Hyperuricosuric Calcium Oxalate Nephrolithiasis
- •Enteric Hyperoxaluria
- •Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Distal Renal Tubular Acidosis
- •Chronic Diarrheal States
- •Thiazide-Induced Hypocitraturia
- •Idiopathic Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Hypomagnesiuric Calcium Nephrolithiasis
- •Gouty Diathesis
- •Cystinuria
- •Infection Lithiasis
- •Summary
- •References
- •12: Molecular Biology for Urologists
- •Introduction
- •Inherited Changes in Cancer Cells
- •VEGR and Cell Signaling
- •Targeting mTOR
- •Conclusion
- •References
- •13: Chemotherapeutic Agents for Urologic Oncology
- •Introduction
- •Bladder Cancer
- •Muscle Invasive Bladder Cancer
- •Metastatic Bladder Cancer
- •Conclusion
- •Prostate Cancer
- •Other Chemotherapeutic Drugs or Combinations for Treating HRPC
- •Conclusion
- •Renal Cell Carcinoma
- •Chemotherapy
- •Immunotherapy
- •Angiogenesis Inhibitor Drugs
- •Conclusion
- •Testicular Cancer
- •Stage I Seminoma
- •Stage I non-seminomatous Germ Cell Tumours (NSGCT)
- •Metastatic Germ Cell Tumours
- •Low-Volume Metastatic Disease (Stage II A/B)
- •Advanced Metastatic Disease
- •Salvage Chemotherapy for Relapsed or Refractory Disease
- •Conclusion
- •Penile Cancer
- •Side Effects of Chemotherapy
- •Conclusion
- •References
- •14: Tumor and Transplant Immunology
- •Antibodies
- •Cytotoxic and T-helper Cells
- •Immunosuppression
- •Induction Therapy
- •Maintenance Therapy
- •Rejection
- •Posttransplant Lymphoproliferative Disease
- •Summary
- •References
- •15: Pathophysiology of Renal Obstruction
- •Causes of Renal Obstruction
- •Effects on Prenatal Development
- •Prenatal Hydronephrosis
- •Spectrum of Renal Abnormalities
- •Renal Functional Changes
- •Renal Growth/Counterbalance
- •Vascular Changes
- •Inflammatory Mediators
- •Glomerular Development Changes
- •Mechanical Stretch of Renal Tubules
- •Unilateral Versus Bilateral
- •Limitations of Animal Models
- •Future Research
- •Issues in Patient Management
- •Diagnostic Imaging
- •Ultrasound
- •Intravenous Urography
- •Antegrade Urography and the Whitaker Test
- •Nuclear Renography
- •Computed Tomography
- •Magnetic Resonance Urography
- •Hypertension
- •Postobstructive Diuresis
- •References
- •Introduction
- •The Normal Lower Urinary Tract
- •Anatomy
- •Storage Function
- •Voiding Function
- •Neural Control
- •Symptoms
- •Flow Rate and Post-void Residual
- •Voiding Cystometry
- •Male
- •Female
- •Neurourology
- •Conclusions
- •References
- •17: Urologic Endocrinology
- •The Testis
- •Normal Androgen Metabolism
- •Epidemiological Aspects
- •Prostate
- •Brain
- •Muscle Mass and Adipose Tissue
- •Bones
- •Ematopoiesis
- •Metabolism
- •Cardiovascular System
- •Clinical Assessment
- •Biochemical Assessment
- •Treatment Modalities
- •Oral Preparations
- •Parenteral Preparations
- •Transdermal Preparations
- •Side Effects and Treatment Monitoring
- •Body Composition
- •Cognitive Decline
- •Bone Metabolism
- •The Kidneys
- •Endocrine Functions of the Kidney
- •Erythropoietin
- •Calcitriol
- •Renin
- •Paraneoplastic Syndromes
- •Hypercalcemia
- •Hypertension
- •Polycythemia
- •Other Endocrine Abnormalities
- •References
- •General Physiology
- •Prostate Innervation
- •Summary
- •References
- •Wound Healing
- •Inflammation
- •Proliferation
- •Remodeling
- •Principles of Plastic Surgery
- •Tissue Characteristics
- •Grafts
- •Flap
- •References
- •Lower Urinary Tract Symptoms
- •Storage Phase
- •Voiding Phase
- •Return to Storage Phase
- •Urodynamic Parameters
- •Urodynamic Techniques
- •Volume Voided Charts
- •Pad Testing
- •Typical Test Schedule
- •Uroflowmetry
- •Post Voiding Residual
- •Further Diagnostic Evaluation of Patients
- •Cystometry with or Without Video
- •Cystometry
- •Videocystometrography (Cystometry + Cystourethrography)
- •Cystometric Findings
- •Comment:
- •Measurements During the Storage Phase:
- •Measurements During the Voiding Phase:
- •Abnormal Function
- •Disorders of Sensation
- •Causes of Hypersensitive Bladder Sensation
- •Causes of Hyposensitive Bladder Sensation
- •Disorders of Detrusor Motor Function
- •Bladder Outflow Tract Dysfunction
- •Detrusor–Urethral Dyssynergia
- •Detrusor–Bladder Neck Dyssynergia
- •Detrusor–Sphincter Dyssynergia
- •Complex Urodynamic Investigation
- •Urethral Pressure Measurement
- •Technique
- •Neurophysiological Evaluation
- •Conclusion
- •References
- •Endoscopy
- •Cystourethroscopy
- •Ureteroscopy and Ureteropyeloscopy
- •Nephroscopy
- •Virtual Reality Simulators
- •Lasers
- •Clinical Application of Lasers
- •Condylomata Acuminata
- •Urolithiasis
- •Benign Prostatic Hyperplasia
- •Ureteral and Urethral Strictures
- •Conclusion
- •References
- •Introduction
- •The Prostatitis Syndromes
- •The Scope of the Problem
- •Category III CP/CPPS
- •The Goal of Treatment
- •Conservative Management
- •Drug Therapy
- •Antibiotics
- •Anti-inflammatories
- •Alpha blockers
- •Hormone Therapies
- •Phytotherapies
- •Analgesics, muscle relaxants and neuromodulators
- •Surgery
- •A Practical Management Plan
- •References
- •Orchitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment of Infectious Orchitis
- •Epididymitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation of Epididymitis
- •Treatment of Acute Epididymitis
- •Treatment of Chronic Epididymitis
- •Treatment of Spermatic Cord Torsion
- •Fournier’s Gangrene
- •Definition and Etiology
- •Risk Factors
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment
- •References
- •Fungal Infections
- •Candidiasis
- •Aspergillosis
- •Cryptococcosis
- •Blastomycosis
- •Coccidioidomycosis
- •Histoplasmosis
- •Radiographic Findings
- •Treatment
- •Tuberculosis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Schistosomiasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Filariasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Onchocerciasis
- •References
- •25: Sexually Transmitted Infections
- •Introduction
- •STIs Associated with Genital Ulcers
- •Herpes Simplex Virus
- •Diagnosis
- •Treatment
- •Chancroid
- •Diagnosis
- •Treatment
- •Syphilis
- •Diagnosis
- •Treatment
- •Lymphogranuloma Venereum
- •Diagnosis
- •Treatment
- •Chlamydia
- •Diagnosis
- •Treatment
- •Gonorrhea
- •Diagnosis
- •Treatment
- •Trichomoniasis
- •Diagnosis
- •Treatment
- •Human Papilloma Virus
- •Diagnosis
- •Treatment
- •Scabies
- •Diagnosis
- •Treatment
- •References
- •26: Hematuria: Evaluation and Management
- •Introduction
- •Classification of Hematuria
- •Macroscopic Hematuria
- •Microscopic Hematuria
- •Dipstick Hematuria
- •Pseudohematuria
- •Factitious Hematuria
- •Menstruation
- •Aetiology
- •Malignancy
- •Urinary Calculi
- •Infection and Inflammation
- •Benign Prostatic Hyperplasia
- •Trauma
- •Drugs
- •Nephrological Causes
- •Assessment
- •History
- •Examination
- •Investigations
- •Dipstick Urinalysis
- •Cytology
- •Molecular Tests
- •Blood Tests
- •Flexible Cystoscopy
- •Upper Urinary Tract Evaluation
- •Renal USS
- •KUB Abdominal X-Ray
- •Intravenous Urography (IVU)
- •Computed Tomography (CT)
- •Retrograde Urogram Studies
- •Magnetic Resonance Imaging (MRI)
- •Additional Tests and Renal Biopsy
- •Intractable Hematuria
- •Loin Pain Hematuria Syndrome
- •References
- •27: Benign Prostatic Hyperplasia (BPH)
- •Historical Background
- •Pathophysiology
- •Patient Assessment
- •Treatment of BPH
- •Watchful Waiting
- •Drug Therapy
- •Interventional Therapies
- •Conclusions
- •References
- •28: Practical Guidelines for the Treatment of Erectile Dysfunction and Peyronie´s Disease
- •Erectile Dysfunction
- •Introduction
- •Diagnosis
- •Basic Evaluation
- •Cardiovascular System and Sexual Activity
- •Optional Tests
- •Treatment
- •Medical Treatment
- •Oral Agents
- •Phosphodiesterase Type 5 (PDE 5) Inhibitors
- •Nonresponders to PDE5 Inhibitors
- •Apomorphine SL
- •Yohimbine
- •Intracavernosal and Intraurethral Therapy
- •Intracavernosal Injection (ICI) Therapy
- •Intraurethral Therapy
- •Vacuum Constriction Devices
- •Surgical Therapy
- •Conclusion
- •Peyronie´s Disease (PD)
- •Introduction
- •Oral Drug Therapy
- •Intralesional Drug Therapy
- •Iontophoresis
- •Radiation Therapy
- •Surgical Therapy
- •References
- •29: Premature Ejaculation
- •Introduction
- •Epidemiology
- •Defining Premature Ejaculation
- •Voluntary Control
- •Sexual Satisfaction
- •Distress
- •Psychosexual Counseling
- •Pharmacological Treatment
- •On-Demand Treatment with Tramadol
- •Topical Anesthetics
- •Phosphodiesterase Inhibitors
- •Surgery
- •Conclusion
- •References
- •30: The Role of Interventional Management for Urinary Tract Calculi
- •Contraindications to ESWL
- •Complications of ESWL
- •PCNL Access
- •Instrumentation for PCNL
- •Nephrostomy Drains Post PCNL
- •Contraindications to PCNL
- •Complications of PCNL
- •Semirigid Ureteroscopy
- •Flexible Ureteroscopy
- •Electrohydraulic Lithotripsy (EHL)
- •Ultrasound
- •Ballistic Lithotripsy
- •Laser Lithotripsy
- •Ureteric Stents
- •Staghorn Calculi
- •Lower Pole Stones
- •Horseshoe Kidneys and Stones
- •Calyceal Diverticula Stones
- •Stones and PUJ Obstruction
- •Treatment of Ureteric Colic
- •Medical Expulsive Therapy (MET)
- •Intervention for Ureteric Stones
- •Stones in Pregnancy
- •Morbid Obesity
- •References
- •Anatomy and Function
- •Pathophysiology
- •Management
- •Optical Urethrotomy/Dilatation
- •Urethral Stents
- •Preoperative Assessment
- •Urethroplasty
- •Anastomotic Urethroplasty
- •Substitution Urethroplasty
- •Grafts Versus Flaps
- •Oral Mucosal Grafts
- •Tissue Engineering
- •Graft Position
- •Conclusion
- •References
- •32: Urinary Incontinence
- •Epidemiology and Risk Factors
- •Pathophysiology
- •Urge Incontinence
- •Conservative Treatments
- •Pharmacotherapy
- •Invasive/ Surgical Therapies
- •Stress Urinary Incontinence
- •Male SUI Therapies
- •Female SUI Therapies
- •Mixed Urinary Incontinence
- •Conclusions
- •References
- •33: Neurogenic Bladder
- •Introduction
- •Examination and Diagnostic Tests
- •History and Physical Examination
- •Imaging
- •Urodynamics (UDS)
- •Evoked Potentials
- •Classifications
- •Somatic Pathways
- •Brain Lesions
- •Cerebrovascular Accident (CVA)
- •Parkinson’s Disease (PD)
- •Multiple Sclerosis
- •Huntington’s Disease
- •Dementias
- •Normal Pressure Hydrocephalus (NPH)
- •Tumors
- •Psychiatric Disorders
- •Spinal Lesions and Pathology
- •Intervertebral Disk Prolapse
- •Spinal Cord Injury (SCI)
- •Transverse Myelitis
- •Peripheral Neuropathies
- •Metabolic Neuropathies
- •Pelvic Surgery
- •Treatment
- •Summary
- •References
- •34: Pelvic Prolapse
- •Introduction
- •Epidemiology
- •Anatomy and Pathophysiology
- •Evaluation and Diagnosis
- •Outcome Measures
- •Imaging
- •Urodynamics
- •Indications for Management
- •Biosynthetics
- •Surgical Management
- •Anterior Compartment Repair
- •Uterine/Apical Prolapse
- •Enterocele Repair
- •Conclusion
- •References
- •35: Urinary Tract Fistula
- •Introduction
- •Urogynecologic Fistula
- •Vesicovaginal Fistula
- •Etiology and Risk Factors
- •Clinical Factors
- •Evaluation and Diagnosis
- •Pelvic Examination
- •Cystoscopy
- •Imaging
- •Treatment
- •Conservative Management
- •Surgical Management
- •Urethrovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Ureterovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Vesicouterine Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Uro-Enteric Fistula
- •Vesicoenteric Fistula
- •Pyeloenteric Fistula
- •Urethrorectal Fistula
- •References
- •36: Urologic Trauma
- •Introduction
- •Kidney
- •Expectant Management
- •Endovascular Therapy
- •Operative Intervention
- •Operative Management: Follow-up
- •Reno-Vascular Injuries
- •Pediatric Renal Injuries
- •Adrenal
- •Ureter
- •Diagnosis
- •Treatment
- •Delayed Diagnosis
- •Bladder and Posterior Urethra
- •Bladder Injuries: Initial Management
- •Bladder Injuries: Formal Repair
- •Anterior Urethral Trauma
- •Fractured Penis
- •Penile Amputation
- •Scrotal and Testicular Trauma
- •Imaging
- •CT-IVP (CT with Delayed Images)
- •Technique
- •Cystogram
- •Technique
- •Retrograde Urethrogram (RUG)
- •Technique
- •Retrograde Pyelogram (RPG)
- •Technique
- •One-Shot IVP
- •Technique
- •References
- •37: Bladder Cancer
- •Who Should Be Investigated?
- •Epidemiology
- •Risk Factors
- •Role of Screening
- •Signs and Symptoms
- •Imaging
- •Cystoscopy
- •Urine Tests
- •PDD-Assisted TUR
- •Pathology
- •NMIBC and Risk Groups
- •Intravesical Chemotherapy
- •Intravesical Immunotherapy
- •Immediate Cystectomy and CIS
- •Radical Cystectomy with Pelvic Lymph Node Dissection
- •sexual function-preserving techniques
- •Bladder-Preservation Treatments
- •Neoadjuvant Chemotherapy
- •Adjuvant Chemotherapy
- •Preoperative Radiotherapy
- •Follow-up After TUR in NMIBC
- •References
- •38: Prostate Cancer
- •Introduction
- •Epidemiology
- •Race
- •Geographic Variation
- •Risk Factors and Prevention
- •Family History
- •Diet and Lifestyle
- •Prevention
- •Screening and Diagnosis
- •Current Screening Recommendations
- •Biopsy
- •Pathology
- •Prognosis
- •Treatment of Prostate Cancer
- •Treatment for Localized Prostate Cancer (T1, T2)
- •Radical Prostatectomy
- •EBRT
- •IMRT
- •Brachytherapy
- •Treatment for Locally Advanced Prostate Cancer (T3, T4)
- •EBRT with ADT
- •Radical Prostatectomy
- •Androgen-Deprivation Therapy
- •Summary
- •References
- •39: The Management of Testis Cancer
- •Presentation and Diagnosis
- •Serum Tumor Markers
- •Primary Surgery
- •Testis Preserving Surgery
- •Risk Stratification
- •Surveillance Versus Primary RPLND
- •Primary RPLND
- •Adjuvant Treatment for High Risk
- •Clinical Stage 1 Seminoma
- •Risk-Stratified Adjuvant Treatment
- •Adjuvant Radiotherapy
- •Adjuvant Low Dose Chemotherapy
- •Primary Combination Chemotherapy
- •Late Toxicity
- •Salvage Strategies
- •Conclusion
- •References
- •Index
477
PElvic ProlaPsE
cele development: congenital, iatrogenic, trac- |
sac, (3) high suture ligation of the peritoneal |
tion, and pulsion. Congenital enteroceles are |
sac, and (4) closure of the defect by providing |
the result of failure of the rectovaginal septum |
support below the peritoneal sac and restora- |
to completely fuse, leaving an open cul-de-sac |
tion of the normal vaginal axis53 (Fig. 34.12). |
or pouch of Douglas, which fills with small |
Enterocele repair usually occurs in combination |
bowel and omentum. Pulsion enteroceles |
with additional prolapse procedures, and can be |
develop in response to conditions leading to |
effectively performed either by an abdominal or |
chronically elevated intra-abdominal pres- |
vaginal approach. |
sures, such as obesity and obstructive airway |
|
diseases, particularly after hysterectomy. |
Conclusion |
Contents of the peritoneum may be pulled |
|
down along with other prolapsing compart- |
|
ments or the uterus in what is termed a trac- |
Pelvic organ prolapse is a relatively common |
tion enterocele. Iatrogenic enteroceles are due |
condition with varying degrees of symptoma- |
to alterations in the vaginal axis created by sur- |
tology. This chapter is meant to provide an over- |
gical procedures for prolapse and incontinence |
view of the epidemiology, evaluation, diagnosis |
(as in the Burch procedure, for example). The |
(including supplemental studies), and treat- |
cul-de-sac is left open by the change in vaginal |
ment of prolapse. Treatment is generally based |
axis, allowing development of the enterocele. |
upon patient assessment of degree of bother |
This can be addressed in a prophylactic man- |
from prolapse, and ranges from conservative |
ner at the time of the prolapse or incontinence |
options such as pessary and/or pelvic floor |
procedure to prevent enterocele formation |
muscle therapy to surgical options, with or |
from occurring at a later date. |
without the use of mesh grafts. Synthetic mesh |
The goals of enterocele repair are to reduce |
has become a hot topic with a recent FDA state- |
the contents and ligate neck of the herniated |
ment that encourages physicians to exercise |
peritoneal sac. Therefore, the principles of |
caution in regard to mesh implantation due to |
enterocele repair are: (1) identification of the |
complications requiring mesh removal and not |
contents of the enterocele, (2) mobilization of |
uncommonly, extensive urinary tract or pelvic |
the enterocele with excision of the peritoneal |
floor reconstruction. |
a |
b |
Figure 34.12. Enterocele repair. the enterocele sac is dissected free and then opened, allowing access into the pelvic cavity. a pursestring suture is placed in the peritoneum circumferentially and tied after bowel contents are reduced. after administering
iv indigo carmine, cystoscopy is performed to confirm ureteral integrity. Excess sac is excised. Before the vaginal incisions are closed, a vault fixation procedure is performed.
478
Practical Urology: EssEntial PrinciPlEs and PracticE
References |
18. |
Am J Obstet Gynecol. 1992;166(6 pt 1):1717-1724 |
|
|
|
Delancey JO et al. Anatomic aspects of vaginal eversion. |
|
1. |
Subak L, Waetjen L, Eeden Svd, Thom D, Vittinghoff E, |
19. |
Badiou W, Granier G, Bousquet P, Monrozies X, Mares P, |
|
Tayrac RD. Comparative histological analysis of anterior |
||
|
Brown J. Cost of pelvic organ prolapse surgery in the |
|
vaginal wall in women with pelvic organ prolapse or |
|
United States. Obstet Gynecol. 2001;98:646-651 |
|
control subjects: a pilot study. Int Urogynecol J. 2008;19: |
2. |
Bradley C, Zimmerman M, Qi Y, Nygaard I. Natural his- |
|
723-729 |
|
tory of pelvic organ prolapse in postmenopausal women. |
20. |
Jackson S, Avery N, Tartlton V, Eckford S, Abrams P, |
|
Obstet Gynecol. 2007;109(4):848-854 |
|
Bailey A. Changes in metabolism of collagen in genito- |
3. |
Nygaard I, Bradley C, Brandt D. Pelvic organ prolapse in |
|
urinary prolapse. Lancet. 1996;347(9016):1658-1661 |
|
older women: prevalence and risk factors.Obstet Gynecol. |
21. |
Moalli P, Talarico L, Sung V, et al. Impact of menopause |
|
2004;104(3):489-497 |
|
on collagen subtypes in the arcus tenineous fasciae |
4. |
Handa V, Garrett E, Hendrix S, Gold E, Robbins |
|
pelvis. Am J Obstet Gynecol. 2004;190:620-627 |
|
J. Progression and remission of pelvic organ prolapse: a |
22. |
Klutke J, Ji Q, Campeau J, et al. Decreased endopelvic fas- |
|
longitudinal study of menopausal women. Am J Obstet |
|
cia elastin content in uterine prolapse. Acta Obstet |
|
Gynecol. 2004;190:27-32 |
|
Gynecol. 2008;87:111-115 |
5. |
Olsen A, Smith V, Bergstrom J, Colling J, Clark A. |
23. |
Karam J, Vazquez D, Lin V, Zimmern P. Elastin expres- |
|
Epidemiology of surgically managed pelvic organ pro- |
|
sion and elastic fibre width in the anterior vaginal wall |
|
lapse and urinary incontinence. Obstet Gynecol. |
|
of postmenopausal women with and without prolapse. |
|
1997;89(4):501-506 |
|
BJU. 2007;100:346-350 |
6. |
Fialkow M, Newton K, Lentz G, Weiss N. Lifetime risk of |
24. |
Goh JT. Biomechanical properties of prolapsed vaginal |
|
surgical management for pelvic organ prolapse or uri- |
|
tissue in preand postmenopausal women. Int |
|
nary incontinence. Int Urogynecol J. 2008;19:437-440 |
|
Urogynecol J Pelvic Floor Dysfunct. 2002;13(2):76-79; |
7. |
Bump RA, Norton PA. Epidemiology and natural history |
|
discussion 79 |
|
of pelvic floor dysfunction. Obstet Gynecol Clin North |
25. |
Cosson M,Lambaudie E,Boukerrou M,Lobry P,Crepin G, |
|
Am. 1998;25(4):723-746 |
|
Ego A. A biomechanical study of the strength of vaginal |
8. |
Rortveit G, Brown J, Thom D, Eeden SVD, Creasman J, |
|
tissues. Results on 16 post-menopausal patients present- |
|
Subak L. Symptomatic pelvic organ prolapse: prevalence |
|
ing with genital prolapse. Eur J Obstet Gynecol Reprod |
|
and risk factors in a population-based, racially diverse |
|
Biol. 2004;112(2):201-205 |
|
cohort. Obstet Gynecol. 2007;109(6):1396-1403 |
26. |
Zimmern PE, Eberhart RC, Bhatt A. Methodology for |
9. |
Hendrix S, Clark A, Nygaard I, Aragaki A, Barnabei V, |
|
biomechanical testing of fresh anterior wall vaginal |
|
McTiernan A. Pelvic organ prolapse in the Women’s |
|
samples from postmenopausal women undergo- |
|
Health Inititative: gravity and gravidity. Am J Obstet |
|
ing cystocele repair. Neurourol Urodyn. 2009;28(4): |
|
Gynecol. 2002;186:1160-1166 |
|
325-329 |
10. |
Sewell C, Chang E, Sultana C. Prevalence of genital pro- |
27. |
Gutman R, Ford D, Quiroz L, Shippey S, Handa V. Is there |
|
lapse in 3 ethnic groups. J Reprod Med. 2007;52(9):769-773 |
|
a pelvic organ prolapse threshold that predicts pelvic |
11. |
Kudish B, Iglesia C, Sokol R, et al. Effect of weight change |
|
floor symptoms? Am J Obstet Gynecol. 2008;6:683.e681- |
|
on natural history of pelvic organ prolapse. Obstet |
|
683.e687 |
|
Gynecol. 2009;113(1):81-88 |
28. |
Bump RC, Mattiasson A, Bo K, et al. The standardization |
12. |
McLennan M, Harris J, Kariuki B, Meyer S. Family his- |
|
of terminology of female pelvic organ prolapse and pel- |
|
tory as a risk factor for pelvic organ prolapse. Int |
|
vic floor dysfunction. Am J Obstet Gynecol. 1996;175(1): |
|
Urogynecol J. 2008;19:1063-1069 |
|
10-17 |
13. |
Altman D, Frosman M, Falconer C, Lichtenstein P. |
29. |
Lowenstein L, Kenton K, Peirce K, FitzGerald M, Mueller |
|
Genetic influence on stress urinary incontinence and |
|
E, Brubaker L. Patients’ pelvic goals change after initial |
|
pelvic organ prolapse. Eur Urol. 2008;54:918-923 |
|
urogynecologic consultation. Am J Obstet Gynecol. |
14. |
Woodman P, Swift S, O’Boyle A, et al. Prevalence of |
|
2007;197:640.e641-640.e643 |
|
severe pelvic organ prolapse in relation to job descrip- |
30. |
Jelovsek J, Barber M. Women seeking treatment for |
|
tion and socioeconomic status: a multi-center cross- |
|
advanced pelvic organ prolapse have decreased body |
|
sectional study. Int Urogynecol J Pelvic Floor Dysfunct. |
|
image and quality of life. Am J Obstet Gynecol. 2006;194: |
|
2006;17(4):340-345 |
|
1455-1461 |
15. |
Swift S. The distribution of pelvic organ support in a |
31. |
Dmochowski RR, Sanders SW, Appell RA, Nitti VW, |
|
population of female subjects seen for routine gyneco- |
|
Davila GW. Bladder-health diaries: an assessment of |
|
logic health care. Am J Obstet Gynecol. 2000;183(2): |
|
3-day vs 7-day entries. BJU Int. 2005;96(7):1049-1054 |
|
277-285 |
32. |
Showalter P, Zimmern P, Roehrborn C, Lemack G. |
16. |
Mant J, Painter R, Vessey M. Epidemiology of genital |
|
Standing cystourethrogram: an outcome measure after |
|
prolapse: observations from the oxford family planning |
|
anti-incontinence procedures and cystocele repair in |
|
association study. Br J Obstet Gynaecol. 1997;104: |
|
women. Urology. 2001;58:33-37 |
|
579-585 |
33. |
Groenendijk A,HulstVvd,Birnie E,Bonsel G.Correlation |
17. |
Lukacz E, Lawrence J, Contreras R, Nager C, Luber K. |
|
between posterior vaginal wall defects assessed by clini- |
|
Parity, mode of delivery, and pelvic floor disorders. |
|
cal examination and by defecography. Int Urogynecol J. |
|
Obstet Gynecol. 2006;107(6):1253-1260 |
|
2008;19:1291-1297 |
479
PElvic ProlaPsE
34.Finco C, Savastano S, Luongo B, et al. Colpocystodefecography in obstructed defecation: is it really useful to the surgeon? Correlating clinical and radiological findings in surgery for obstructed defecation. Colorectal Dis. 2007;10:446-452
35.Grody M. Urinary incontinence and concomitant prolapse. Clin Obstet Gynecol. 1998;41:777-785
36.Long C,Hsu S,Wu T,Sun D,Su J,Tsai E.Urodynamic comparison of continent and incontinent women with severe urogenital prolapse. J Reprod Med. 2004;49(1):33-37
37.Brubaker L, Cundiff G, Fine P, et al. Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence. N Engl J Med. 2006;354(15): 1557-1566
38.Gilleran J, Lemack G, Zimmern P. Reduction of moderate to large cystocele during urodynamic evaluation using a vaginal gauze pack: 8-year experience. Br J Urol. 2005;97:292-295
39.Glazener C, Lapitan M. Urodynamic investigations for management of urinary incontinence in children and adults. Cochrane Database Syst Rev. 2002; Issue 3, Art. No. CD003195. doi: 10.1002/14651858.CD003195
40.Maher C, Baessler K, Glazener C, Adams E, Hagen S. Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev. 2007; Issue 3, Art. No. CD004014. doi: 10.1002/14651858.CD004014.pub.3
41.Ballert K, Biggs G, Isenalumhe A, Rosenblum N, Nitti V. Managing the urethra at transvaginal pelvic organ prolapse repair: a urodynamic approach. J Urol. 2009;181:679-684
42.Bradley C, Kenton K, Gao X, Zyczynski H, Weber A, Nygaard I. Obestiy and outcomes after sacrocolpopexy. Am J Obstet Gynecol. 2008;199(6):690.e691690.e698
43.Clemons J, Aguilar V, Tillinghast T, Jackson N, Myers D. Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse. Am J Obstet Gynecol. 2004;190:1025-1029
44.Maito J, Quam Z, Craig E, Danner K, Rogers R. Predictors of successful pessary fitting and continued use in a nurse-midwifery pessary clinic. J Midwifery Womens Health. 2006;51:78-84
45.Fernando R, Thakar R, Sultan A, Shah S, Jones P. Effect of vaginal pessaries on symptoms associated with pelvic organ prolapse. Obstet Gynecol. 2006;108(1):93-99
46.Clemons J, Aguilar V, Tillinghast T, Jackson N, Myers D. Risk factors associated with an unsuccessful pessary fitting trial in women with pelvic organ prolapse. Am J Obstet Gynecol. 2004;190:345-350
47.Barber M, Walters M, Cundiff G. Responsiveness of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ) in women undergoing vaginal urgery and pessary treatment for pelvic organ prolapse. Am J Obstet Gynecol. 2006;194:1492-1498
48.Piva-Anant M, Therasakvichya S, Leelaphatanadit C, Techantrisak K. Integrated health research program for the Thai elderly: prevalence of genital prolapse and effectiveness of pelvic floor exercise to prevent worsening of genital prolapse in elderly women. J Med Assoc Thai. 2003;86(6):509-515
49.Simonds R, Holmberg S, Hurwitz R, et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med. 1992;326(11):726-732
50.Riccetto C, Miyaoka R, DeFraga R, et al. Impact of the structure of polypropylene meshes in local tissue reaction: in vivo stereological study. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(8):1117-1123
51.Huebner M, Hsu Y, Fenner D. The use of graft materials in vaginal pelvic floor surgery. Int J Gynecol Obstet. 2006;92:279-288
52.Diwadkar G, Barber M, Feiner J, Maher C, Jelovsek J. Complication and reoperation rates after apical vaginal prolapse surgical repair: a systematic review. Obstet Gynecol. 2009;113(2):367-373
53.Nichols D, Randall C. Vaginal Surgery. 4th ed. Baltimore, MD: Williams & Wilkins; 1996